Quantitative MRCP metrics as imaging biomarkers to differentiate benign from malignant bile duct obstructions
Quantitative MRCP metrics, particularly total biliary tree volume, are shown here to differentiate malignant (CCA) from benign obstructions. As current pathways require either contrast administration or ERCP, quantitative MRCP may be an objective, non-invasive tool to identify CCA.
Authors
- Mukesh G. Harisinghani (ORCID: https://orcid.org/0000-0003-0993-1947)
- Chalerm Eurboonyanun (ORCID: https://orcid.org/0000-0002-8103-1364)
- Elizabeth Shumbayawonda (ORCID: https://orcid.org/0000-0003-0351-2063)
- Sarah L. Finnegan (ORCID: https://orcid.org/0000-0003-2249-7612)
- Aileen O’Shea (ORCID: https://orcid.org/0000-0002-2172-7087)
- Prakasit Sa-Ngiamwibool (ORCID: https://orcid.org/0000-0002-5090-6594)
- Carlos Ferreira
- Julaluck Promsorn (ORCID: https://orcid.org/0000-0001-5852-004X)
- Amy H. Herlihy (ORCID: https://orcid.org/0000-0002-2997-2554)
- Isha D. Atre (ORCID: https://orcid.org/0000-0001-7629-0129)
- Kulyada Eurboonyanun (ORCID: https://orcid.org/0000-0003-4074-9297)
- Rita Maria Lahoud (ORCID: https://orcid.org/0000-0001-9849-3699)
Institutions
- Tufts Medical Center (US)
- Khon Kaen University (TH)
- Massachusetts General Hospital (US)
- Translational Research in Oncology (FR)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-05-06
- DOI
- https://doi.org/10.3389/fonc.2025.1576163
- Citations
- 2
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.01
Funders
- Khon Kaen University